Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Awakn Life Sciences Corp (AWKNF)

Awakn Life Sciences Corp (AWKNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Awakn Life Sciences Announces Upsizing and Closing of Tranche of Private Placement Financing Newsfile - Wed Sep 18, 6:42AM CDT

Toronto, Ontario--(Newsfile Corp. - September 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0602 (-19.73%)
AWKN.CN : 0.0900 (-5.26%)
Awakn Announces Key Progress in Its Aminoindane Pre-Clinical Program Newsfile - Wed Aug 28, 6:38AM CDT

Toronto, Ontario--(Newsfile Corp. - August 28, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF), a clinical-stage biotechnology company developing therapeutics for substance use and mental...

AWKNF : 0.0602 (-19.73%)
AWKN.CN : 0.0900 (-5.26%)
Awakn Announces First Patient Screened in Phase 3 Clinical Trial of AWKN-001 for Severe Alcohol Use Disorder Newsfile - Fri Aug 9, 6:38AM CDT

Toronto, Ontario--(Newsfile Corp. - August 9, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0602 (-19.73%)
AWKN.CN : 0.0900 (-5.26%)
Awakn Life Sciences Announces Closing of Tranche of Private Placement and Warrant Extension Newsfile - Wed Jul 31, 6:34AM CDT

Toronto, Ontario--(Newsfile Corp. - July 31, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0602 (-19.73%)
AWKN.CN : 0.0900 (-5.26%)
Awakn Life Sciences Provides Update on Aminoindane New Chemical Entity Patent Portfolio Newsfile - Mon Jul 22, 4:10PM CDT

Toronto, Ontario--(Newsfile Corp. - July 22, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0602 (-19.73%)
AWKN.CN : 0.0900 (-5.26%)
Awakn Life Sciences Announces Collaboration Agreement with Graft Polymer (UK) PLC Newsfile - Thu Jul 18, 6:34AM CDT

Toronto, Ontario--(Newsfile Corp. - July 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0602 (-19.73%)
AWKN.CN : 0.0900 (-5.26%)
Awakn Life Sciences Announces Closing of Tranche of Private Placement Newsfile - Tue Jun 4, 6:42AM CDT

Toronto, Ontario--(Newsfile Corp. - June 4, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.0602 (-19.73%)
AWKN.CN : 0.0900 (-5.26%)
Awakn Life Sciences Discusses Filing of Financial Statements Newsfile - Thu May 2, 5:16PM CDT

Toronto, Ontario--(Newsfile Corp. - May 2, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.0602 (-19.73%)
AWKN.CN : 0.0900 (-5.26%)
Awakn Life Sciences Announces Closing of Tranche of Private Placement Newsfile - Wed Apr 17, 6:34AM CDT

Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.0602 (-19.73%)
AWKN.CN : 0.0900 (-5.26%)
Awakn Life Sciences Announces Launch of Licensing Partnership Agreement with Oklahoma Based Clinic Newsfile - Wed Apr 3, 6:32AM CDT

Awakn also announces Private PlacementToronto, Ontario--(Newsfile Corp. - April 3, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology...

AWKNF : 0.0602 (-19.73%)
AWKN.CN : 0.0900 (-5.26%)

Barchart Exclusives

How Surging AI Demand Could Drive This Dividend Stock Higher Barchart - Thu Sep 19, 6:30PM CDT
Eaton, a diversified power management company, is poised to benefit from the surging demand for AI-driven data centers, with its innovative power solutions and strong dividend growth making it an attractive investment opportunity. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot